Sort by

Send to

Choose Destination

Links from PubMed

Items: 16


Cardiac troponin trends and severity in chronic obstructive pulmonary disease exacerbation: Are limits properly associated for Intensive Care Unit outcome?

Yıldırım F, Esquinas AM.

Lung India. 2016 Sep-Oct;33(5):583-4. doi: 10.4103/0970-2113.189007. No abstract available.


Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.

Wells JM, Morrison JB, Bhatt SP, Nath H, Dransfield MT.

Chest. 2016 May;149(5):1197-204. doi: 10.1378/chest.15-1504.


Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study.

Mebazaa A, Casadio MC, Azoulay E, Guidet B, Jaber S, Levy B, Payen D, Vicaut E, Resche-Rigon M, Gayat E.

BMC Anesthesiol. 2015 Oct 12;15:143. doi: 10.1186/s12871-015-0129-2.


Chief Complaint at Admission Relates to Troponin Level and Mortality in Patients With Non-ACS Troponin Elevation.

Piscator E, Lowing Svensson L, Svensson P.

J Clin Med Res. 2015 Jun;7(6):464-71. doi: 10.14740/jocmr2143w.


The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD.

Buchan A, Bennett R, Coad A, Barnes S, Russell R, Manuel AR.

Open Heart. 2015 Mar 26;2(1):e000052. doi: 10.1136/openhrt-2014-000052. Review.


Prognostic value of serum growth differentiation factor-15 in patients with chronic obstructive pulmonary disease exacerbation.

Kim M, Cha SI, Choi KJ, Shin KM, Lim JK, Yoo SS, Lee J, Lee SY, Kim CH, Park JY, Yang DH.

Tuberc Respir Dis (Seoul). 2014 Dec;77(6):243-50. doi: 10.4046/trd.2014.77.6.243.


The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations ofchronic obstructive pulmonary disease.

Høiseth AD, Neukamm A, Hagve TA, Omland T, Brekke PH, Søyseth V.

Open Heart. 2014 Jan 15;1(1):e000001. doi: 10.1136/openhrt-2013-000001.


Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.

Laratta CR, van Eeden S.

Biomed Res Int. 2014;2014:528789. doi: 10.1155/2014/528789. Review.


Acute liver failure and elevated troponin-I: controversial results and significance?

Jaber S, Paugam-Burtz C.

Crit Care. 2013 Jan 14;17(1):102. doi: 10.1186/cc11897.


Troponin elevation in conditions other than acute coronary syndromes.

Tanindi A, Cemri M.

Vasc Health Risk Manag. 2011;7:597-603. doi: 10.2147/VHRM.S24509. Review.


Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease.

Pabst S, Theis B, Gillissen A, Lennarz M, Tuleta I, Nickenig G, Skowasch D, Grohé C.

Eur J Med Res. 2009 Dec 7;14 Suppl 4:177-81.


Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study.

Brekke PH, Omland T, Holmedal SH, Smith P, Søyseth V.

BMC Pulm Med. 2009 Jul 19;9:35. doi: 10.1186/1471-2466-9-35.


Raised cardiac troponin T levels in patients without acute coronary syndrome.

Wong P, Murray S, Ramsewak A, Robinson A, van Heyningen C, Rodrigues E.

Postgrad Med J. 2007 Mar;83(977):200-5.


Elevated troponin and myocardial infarction in the intensive care unit: a prospective study.

Lim W, Qushmaq I, Cook DJ, Crowther MA, Heels-Ansdell D, Devereaux PJ; Troponin T Trials Group..

Crit Care. 2005;9(6):R636-44.

Items per page

Supplemental Content

Support Center